FOXQ1 and hepatocellular carcinoma: In general, high FOXQ1 expression appears to be associated with a poor clinical outcome, and has been identified as an independent prognostic marker for worse survival in colorectal, pancreatic, lung, gastric, and hepatocellular carcinomas (HCC) [26–28, 30, 31].